These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 35967376)

  • 1. Innate immunity and microbial dysbiosis in hidradenitis suppurativa - vicious cycle of chronic inflammation.
    Chopra D; Arens RA; Amornpairoj W; Lowes MA; Tomic-Canic M; Strbo N; Lev-Tov H; Pastar I
    Front Immunol; 2022; 13():960488. PubMed ID: 35967376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Yin and Yang: A disrupted skin microbiome and an aberrant host immune response in hidradenitis suppurativa.
    Schell SL; Schneider AM; Nelson AM
    Exp Dermatol; 2021 Oct; 30(10):1453-1470. PubMed ID: 34018644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The skin transcriptome in hidradenitis suppurativa uncovers an antimicrobial and sweat gland gene signature which has distinct overlap with wounded skin.
    Coates M; Mariottoni P; Corcoran DL; Kirshner HF; Jaleel T; Brown DA; Brooks SR; Murray J; Morasso MI; MacLeod AS
    PLoS One; 2019; 14(5):e0216249. PubMed ID: 31059533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hidradenitis Suppurativa: Consequences of Microbiome Dysbiosis on Immune Dysregulation and Disease Severity.
    Chung MG; Preda-Naumescu A; Yusuf N
    Indian J Dermatol; 2022; 67(6):699-704. PubMed ID: 36998859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hidradenitis suppurativa: A folliculotropic disease of innate immune barrier dysfunction?
    Johnston DGW; Kirby B; Tobin DJ
    Exp Dermatol; 2021 Oct; 30(10):1554-1568. PubMed ID: 34418166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in innate immunity and epithelial cell differentiation are the molecular pillars of hidradenitis suppurativa.
    Zouboulis CC; Nogueira da Costa A; Makrantonaki E; Hou XX; Almansouri D; Dudley JT; Edwards H; Readhead B; Balthasar O; Jemec GBE; Bonitsis NG; Nikolakis G; Trebing D; Zouboulis KC; Hossini AM
    J Eur Acad Dermatol Venereol; 2020 Apr; 34(4):846-861. PubMed ID: 31838778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hidradenitis Suppurativa: A Systematic Review Integrating Inflammatory Pathways Into a Cohesive Pathogenic Model.
    Vossen ARJV; van der Zee HH; Prens EP
    Front Immunol; 2018; 9():2965. PubMed ID: 30619323
    [No Abstract]   [Full Text] [Related]  

  • 8. Microbiome in Hidradenitis Suppurativa-What We Know and Where We Are Heading.
    Świerczewska Z; Lewandowski M; Surowiecka A; Barańska-Rybak W
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistological pointers to a possible role for excessive cathelicidin (LL-37) expression by apocrine sweat glands in the pathogenesis of hidradenitis suppurativa/acne inversa.
    Emelianov VU; Bechara FG; Gläser R; Langan EA; Taungjaruwinai WM; Schröder JM; Meyer KC; Paus R
    Br J Dermatol; 2012 May; 166(5):1023-34. PubMed ID: 22136668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of the Cutaneous Microbiome in Hidradenitis Suppurativa-Light at the End of the Microbiological Tunnel.
    Langan EA; Recke A; Bokor-Billmann T; Billmann F; Kahle BK; Zillikens D
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32054085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A gene dysfunction module reveals the underlying pathogenesis of hidradenitis suppurativa: An update.
    Li X; Jiang L; Huang Y; Ren Z; Liang X; Wang P
    Australas J Dermatol; 2020 Feb; 61(1):e10-e14. PubMed ID: 31266094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the Complement Pathway in Inflammatory Skin Diseases: A Focus on Hidradenitis Suppurativa.
    Ghias MH; Hyde MJ; Tomalin LE; Morgan BP; Alavi A; Lowes MA; Piguet V
    J Invest Dermatol; 2020 Mar; 140(3):531-536.e1. PubMed ID: 31870626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Skin and Gut Microbiome in Hidradenitis Suppurativa: Current Understanding and Future Considerations for Research and Treatment.
    Luck ME; Tao J; Lake EP
    Am J Clin Dermatol; 2022 Nov; 23(6):841-852. PubMed ID: 36116091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skin immunity and its dysregulation in atopic dermatitis, hidradenitis suppurativa and vitiligo.
    Campione E; Lanna C; Diluvio L; Cannizzaro MV; Grelli S; Galluzzo M; Talamonti M; Annicchiarico-Petruzzelli M; Mancini M; Melino G; Candi E; Schiavone G; Wang Y; Shi Y; Bianchi L
    Cell Cycle; 2020 Feb; 19(3):257-267. PubMed ID: 31905036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of innate defense antimicrobial peptides in hidradenitis suppurativa.
    Hofmann SC; Saborowski V; Lange S; Kern WV; Bruckner-Tuderman L; Rieg S
    J Am Acad Dermatol; 2012 Jun; 66(6):966-74. PubMed ID: 21982063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacteriology of hidradenitis suppurativa/acne inversa: A review.
    Nikolakis G; Join-Lambert O; Karagiannidis I; Guet-Revillet H; Zouboulis CC; Nassif A
    J Am Acad Dermatol; 2015 Nov; 73(5 Suppl 1):S12-8. PubMed ID: 26470608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inborn Errors of Immunity in Hidradenitis Suppurativa Pathogenesis and Disease Burden.
    Colvin A; Petukhova L
    J Clin Immunol; 2023 Aug; 43(6):1040-1051. PubMed ID: 37204644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial peptides in hidradenitis suppurativa: a systematic review.
    Yao Y; Frew JW; Thomsen SF; Ring HC
    Br J Dermatol; 2022 Feb; 186(2):236-244. PubMed ID: 34498267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement activation in Hidradenitis suppurativa: Covert low-grade inflammation or innocent bystander?
    van Straalen KR; Dudink K; Aarts P; van der Zee HH; van den Bosch TPP; Giang J; Prens EP; Damman J
    Front Immunol; 2022; 13():953674. PubMed ID: 36211440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hidradenitis Suppurativa and 1-Carbon Metabolism: Role of Gut Microbiome, Matrix Metalloproteinases, and Hyperhomocysteinemia.
    Molnar J; Mallonee CJ; Stanisic D; Homme RP; George AK; Singh M; Tyagi SC
    Front Immunol; 2020; 11():1730. PubMed ID: 32973741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.